IOBTQ
IO Biotech, Inc.Company with tickers: IOBT
CIK
1865494
CUSIP
449778109
Shares Outstanding
71,948,842
13F Activity (30d)
13 filings
11 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,355,000 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Research & Development | $13,742,000 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Operating Income | $-19,355,000 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Net Income | $-8,378,000 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| EPS (Basic) | $-0.13 | USD/shares | 2025-09-30 | 10-Q | 2025-11-14 |
| EPS (Diluted) | $-0.13 | USD/shares | 2025-09-30 | 10-Q | 2025-11-14 |